In the latest session, Bio-Techne Corp (NASDAQ: TECH) closed at $67.05 down -1.21% from its previous closing price of $67.87. In other words, the price has decreased by -$0.82 from its previous closing price. On the day, 858802 shares were traded.
Ratios:
For a deeper understanding of Bio-Techne Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 77.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 46.76. For the most recent quarter (mrq), Quick Ratio is recorded 3.03 and its Current Ratio is at 4.37. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on February 08, 2024, initiated with a Sector Outperform rating and assigned the stock a target price of $80.
On February 02, 2024, Stifel Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $65.
On December 07, 2023, UBS started tracking the stock assigning a Buy rating and target price of $80.UBS initiated its Buy rating on December 07, 2023, with a $80 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 07 ’24 when Nusse Roeland sold 10,400 shares for $76.98 per share. The transaction valued at 800,627 led to the insider holds 43,097 shares of the business.
Nusse Roeland sold 8,939 shares of TECH for $717,959 on Aug 30 ’23. The Director now owns 51,872 shares after completing the transaction at $80.32 per share. On Jul 21 ’23, another insider, Kummeth Charles R., who serves as the Chief Executive Officer of the company, sold 80,000 shares for $88.36 each. As a result, the insider received 7,069,024 and left with 1,258,766 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TECH now has a Market Capitalization of 10.53B and an Enterprise Value of 10.96B. As of this moment, Bio-Techne’s Price-to-Earnings (P/E) ratio for their current fiscal year is 48.35, and their Forward P/E ratio for the next fiscal year is 32.99. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 7.34. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.20 while its Price-to-Book (P/B) ratio in mrq is 5.37. Its current Enterprise Value per Revenue stands at 9.57 whereas that against EBITDA is 29.14.
Stock Price History:
Over the past 52 weeks, TECH has reached a high of $89.91, while it has fallen to a 52-week low of $51.79. The 50-Day Moving Average of the stock is 71.23, while the 200-Day Moving Average is calculated to be 72.36.
Shares Statistics:
For the past three months, TECH has traded an average of 1.08M shares per day and 1M over the past ten days. A total of 157.64M shares are outstanding, with a floating share count of 155.58M. Insiders hold about 1.03% of the company’s shares, while institutions hold 100.35% stake in the company. Shares short for TECH as of Mar 15, 2024 were 5.1M with a Short Ratio of 4.70, compared to 4.73M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.24% and a Short% of Float of 4.21%.
Dividends & Splits
According to the company, the forward annual dividend rate for TECH is 0.32, from 0.32 in the trailing year. Against a Trailing Annual Dividend Yield of 0.47%, it implies a Forward Annual Dividend Yield of 0.47%. The stock’s 5-year Average Dividend Yield is 0.44. The current Payout Ratio is 18.16% for TECH, which recently paid a dividend on Feb 26, 2024 with an ex-dividend date of Feb 09, 2024. Stock splits for the company last occurred on Dec 04, 2000 when the company split stock in a 2:1 ratio.
Earnings Estimates
There are 13 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.45 for the current quarter, with a high estimate of $0.5 and a low estimate of $0.42, while EPS last year was $0.53. The consensus estimate for the next quarter is $0.49, with high estimates of $0.52 and low estimates of $0.45.
Analysts are recommending an EPS of between $1.83 and $1.67 for the fiscal current year, implying an average EPS of $1.75. EPS for the following year is $2.02, with 12 analysts recommending between $2.12 and $1.87.
Revenue Estimates
A total of 13 analysts have provided revenue estimates for TECH’s current fiscal year. The highest revenue estimate was $1.16B, while the lowest revenue estimate was $1.14B, resulting in an average revenue estimate of $1.15B. In the same quarter a year ago, actual revenue was $1.14B, up 1.00% from the average estimate. Based on 12 analysts’ estimates, the company’s revenue will be $1.25B in the next fiscal year. The high estimate is $1.27B and the low estimate is $1.23B. The average revenue growth estimate for next year is up 8.70% from the average revenue estimate for this year.
